Aptevo Therapeutics (APVO) Gross Margin (2015 - 2019)
Aptevo Therapeutics (APVO) posted Gross Margin of 32.06% for Q4 2019, up 2.37 percentage points from 29.69% a year earlier but down 24.01 percentage points from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Gross Margin (2015 - 2019) Analysis & Trends
For FY2019, Aptevo Therapeutics' Gross Margin came in at 38.54%, down 12.84 percentage points from FY2018.
- Annual Gross Margin shows a four-year change of -11.06 percentage points (FY2015 to FY2019).
- In prior years, Aptevo Therapeutics' Gross Margin was 51.39% in FY2018 (-14.44 pp), 65.82% in FY2017 (+90.68 pp), -24.86% in FY2016 (-74.46 pp) and 49.61% in FY2015.
- Quarterly Gross Margin has run from a low of -67.24% in Q2 2017 to a high of 77.22% in Q1 2017 over five years.
- On a year-over-year basis, Gross Margin increased in two of the last eight quarters, with an average year-over-year change of +4.96 percentage points.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q2 2018, with a gain of 130.12 percentage points; the weakest was Q2 2017, with a drop of 103.04 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 56.06% (Q3 2019), 18.68% (Q2 2019) and 45.22% (Q1 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Aptevo Therapeutics | 2.71 Mn | -64.29 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 32.06% |
| Sep 30, 2019 | 56.06% |
| Jun 30, 2019 | 18.68% |
| Mar 31, 2019 | 45.22% |
| Dec 31, 2018 | 29.69% |
| Sep 30, 2018 | 58.16% |
| Jun 30, 2018 | 62.88% |
| Mar 31, 2018 | 56.25% |
| Dec 31, 2017 | 32.72% |
| Sep 30, 2017 | 69.67% |
| Jun 30, 2017 | -67.24% |
| Mar 31, 2017 | 77.22% |
| Dec 31, 2016 | 42.07% |
| Sep 30, 2016 | -45.95% |
| Jun 30, 2016 | 35.80% |
| Mar 31, 2016 | 56.27% |
| Dec 31, 2015 | 36.80% |
| Sep 30, 2015 | 46.28% |
| Jun 30, 2015 | 37.39% |
API Access
Aptevo Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();